202 related articles for article (PubMed ID: 15197337)
1. Aggressive basal cell carcinoma: presentation, pathogenesis, and management.
Walling HW; Fosko SW; Geraminejad PA; Whitaker DC; Arpey CJ
Cancer Metastasis Rev; 2004; 23(3-4):389-402. PubMed ID: 15197337
[TBL] [Abstract][Full Text] [Related]
2. Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1 alpha-directed invasion of human basal cell carcinoma cells.
Chu CY; Cha ST; Chang CC; Hsiao CH; Tan CT; Lu YC; Jee SH; Kuo ML
Oncogene; 2007 Apr; 26(17):2491-501. PubMed ID: 17099730
[TBL] [Abstract][Full Text] [Related]
3. Axillary basal cell carcinoma--a rare form of a frequent kind of carcinoma.
Costescu M; Coman OA; Tampa M; Tudose I; Coman L; Georgescu SR
Rom J Morphol Embryol; 2013; 54(3 Suppl):851-6. PubMed ID: 24322039
[TBL] [Abstract][Full Text] [Related]
4. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
[TBL] [Abstract][Full Text] [Related]
5. Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients.
Lott DG; Manz R; Koch C; Lorenz RR
Transplantation; 2010 Sep; 90(6):683-7. PubMed ID: 20808266
[TBL] [Abstract][Full Text] [Related]
6. Variations in clinical presentation of basal cell carcinoma.
Buljan M; Bulat V; Situm M; Mihić LL; Stanić-Duktaj S
Acta Clin Croat; 2008 Mar; 47(1):25-30. PubMed ID: 18714644
[TBL] [Abstract][Full Text] [Related]
7. Microarray profiles of human basal cell carcinoma: insights into tumor growth and behavior.
Howell BG; Solish N; Lu C; Watanabe H; Mamelak AJ; Freed I; Wang B; Sauder DN
J Dermatol Sci; 2005 Jul; 39(1):39-51. PubMed ID: 15978418
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
9. Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Scalvenzi M; Salvatore G; Errico ME; Fanali S; De Rosa G; Piattelli A
Anticancer Res; 2001; 21(6A):3757-64. PubMed ID: 11911244
[TBL] [Abstract][Full Text] [Related]
10. [Specific characteristics of skin basal cell carcinoma invasion].
Doĭkova NG; Chernyĭ AP; Chipysheva TA; Gel'shteĭn VI
Arkh Patol; 2000; 62(3):29-33. PubMed ID: 10897434
[TBL] [Abstract][Full Text] [Related]
11. Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management.
Geist DE; Garcia-Moliner M; Fitzek MM; Cho H; Rogers GS
Dermatol Surg; 2008 Dec; 34(12):1642-51. PubMed ID: 19018830
[TBL] [Abstract][Full Text] [Related]
12. Giant basal cell carcinoma of the skin: literature review and personal experience.
Zoccali G; Pajand R; Papa P; Orsini G; Lomartire N; Giuliani M
J Eur Acad Dermatol Venereol; 2012 Aug; 26(8):942-52. PubMed ID: 22211959
[TBL] [Abstract][Full Text] [Related]
13. Management of periorbital basal cell carcinoma with orbital invasion.
Sun MT; Wu A; Figueira E; Huilgol S; Selva D
Future Oncol; 2015 Nov; 11(22):3003-10. PubMed ID: 26437207
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
15. Metastatic basal cell carcinoma of the posterior neck: case report and review of the literature.
Gropper AB; Girouard SD; Hojman LP; Huang SJ; Qian X; Murphy GF; Vleugels RA
J Cutan Pathol; 2012 May; 39(5):526-34. PubMed ID: 22515224
[TBL] [Abstract][Full Text] [Related]
16. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
[TBL] [Abstract][Full Text] [Related]
17. Assessing current treatment options for patients with severe/advanced basal cell carcinoma.
Weinstock MA; Still JM
Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S10-3. PubMed ID: 22177101
[TBL] [Abstract][Full Text] [Related]
18. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.
Ramachandran S; Lear JT; Ramsay H; Smith AG; Bowers B; Hutchinson PE; Jones PW; Fryer AA; Strange RC
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):61-7. PubMed ID: 9950241
[TBL] [Abstract][Full Text] [Related]
19. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]